###begin article-title 0
###xml 60 61 60 61 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 107 108 107 108 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
Selective coupling of type 6 adenylyl cyclase with type 2 IP3 receptors mediates direct sensitization of IP3 receptors by cAMP
###end article-title 0
###begin p 1
###xml 35 52 35 52 <email xmlns:xlink="http://www.w3.org/1999/xlink">cwt1000@cam.ac.uk</email>
Correspondence to Colin W. Taylor: cwt1000@cam.ac.uk
###end p 1
###begin p 2
This article is distributed under the terms of an Attribution-Noncommercial-Share Alike-No Mirror Sites license for the first six months after the publication date (see ). After six months it is available under a Creative Commons License (Attribution-Noncommercial-Share Alike 3.0 Unported license, as described at ).
###end p 2
###begin p 3
###xml 65 67 65 67 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 276 277 276 277 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 285 286 285 286 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 325 326 325 326 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 420 421 420 421 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 467 468 467 468 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 664 665 664 665 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 674 675 674 675 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 742 743 742 743 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 823 825 823 825 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 930 931 930 931 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 579 584 <span type="species:ncbi:9606">Human</span>
Interactions between cyclic adenosine monophosphate (cAMP) and Ca2+ are widespread, and for both intracellular messengers, their spatial organization is important. Parathyroid hormone (PTH) stimulates formation of cAMP and sensitizes inositol 1,4,5-trisphosphate receptors (IP3R) to IP3. We show that PTH communicates with IP3R via "cAMP junctions" that allow local delivery of a supramaximal concentration of cAMP to IP3R, directly increasing their sensitivity to IP3. These junctions are robust binary switches that are digitally recruited by increasing concentrations of PTH. Human embryonic kidney cells express several isoforms of adenylyl cyclase (AC) and IP3R, but IP3R2 and AC6 are specifically associated, and inhibition of AC6 or IP3R2 expression by small interfering RNA selectively attenuates potentiation of Ca2+ signals by PTH. We define two modes of cAMP signaling: binary, where cAMP passes directly from AC6 to IP3R2; and analogue, where local gradients of cAMP concentration regulate cAMP effectors more remote from AC. Binary signaling requires localized delivery of cAMP, whereas analogue signaling is more dependent on localized cAMP degradation.
###end p 3
###begin p 4
S.C. Tovey, S.G. Dedos, and E.J.A. Taylor contributed equally to this paper.
###end p 4
###begin p 5
###xml 422 423 422 423 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 457 458 457 458 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 463 464 463 464 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 502 503 502 503 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 520 521 520 521 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 664 666 664 666 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 271 276 <span type="species:ncbi:9606">human</span>
###xml 332 337 <span type="species:ncbi:9606">human</span>
Abbreviations used in this paper: AC, adenylyl cyclase; AKAP, A kinase-anchoring protein; CCh, carbachol; CNGC, cyclic nucleotide-gated cation channel; DDA, 2',5'-dideoxyadenosine; epac, exchange protein activated by cAMP; FK, forskolin; HBS, Hepes-buffered saline; HEK, human embryonic kidney; HEK-PR1, HEK cells stably expressing human type I PTH receptors; IBMX, 3-isobutyl-1-methylxanthine; IP, immunoprecipitation; IP3, inositol 1,4,5-trisphosphate; IP3R, IP3 receptor; PDE, phosphodiesterase; PGE1, prostaglandin E1; PKA, protein kinase A; PTH, parathyroid hormone; QPCR, quantitative PCR; RpcAMPS, adenosine 3',5'-cyclic phosphorothioate-Rp; SERCA, SR/ER Ca2+-ATPase; SQ 22536, 9-(tetrahydro-2'-furyl)adenine; SR, sarcoplasmic reticulum; WB, Western blot.
###end p 5
###begin title 6
Introduction
###end title 6
###begin p 7
###xml 92 94 92 94 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 354 356 354 356 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 358 372 358 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib3">Berridge, 1997</xref>
###xml 383 407 383 407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib55">Zaccolo and Pozzan, 2002</xref>
###xml 409 430 409 430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib30">Mongillo et al., 2006</xref>
###xml 432 450 432 450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib40">Smith et al., 2006</xref>
###xml 452 479 452 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib50">Willoughby and Cooper, 2007</xref>
###xml 600 602 600 602 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 664 678 664 678 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib3">Berridge, 1997</xref>
###xml 680 707 680 707 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib20">Gorbunova and Spitzer, 2002</xref>
###xml 709 729 709 729 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib17">Dyachok et al., 2006</xref>
###xml 818 820 818 820 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 822 841 822 841 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib16">Dupont et al., 2003</xref>
###xml 987 1005 987 1005 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib7">Bruce et al., 2003</xref>
###xml 1007 1025 1007 1025 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib49">Werry et al., 2003</xref>
###xml 1027 1048 1027 1048 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib37">Screaton et al., 2004</xref>
###xml 1050 1077 1050 1077 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib50">Willoughby and Cooper, 2007</xref>
###xml 1082 1084 1082 1084 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 1337 1338 1337 1338 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1361 1363 1361 1363 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 1409 1411 1409 1411 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 1493 1503 1493 1503 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib5">Bray, 1995</xref>
###xml 1543 1545 1543 1545 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
Cells use a limited repertoire of diffusible intracellular messengers, including cAMP and Ca2+, to regulate most aspects of their behavior, yet they succeed in responding appropriately to a barrage of extracellular signals. The versatility of intracellular messengers is increased by their precise spatial and temporal organization. Local increases in Ca2+ (Berridge, 1997) or cAMP (Zaccolo and Pozzan, 2002; Mongillo et al., 2006; Smith et al., 2006; Willoughby and Cooper, 2007) can selectively regulate closely associated proteins, whereas more global changes regulate different processes. Both Ca2+ and cAMP can also be delivered in precise temporal patterns (Berridge, 1997; Gorbunova and Spitzer, 2002; Dyachok et al., 2006). The frequencies of these messenger spikes are important in determining responses to Ca2+ (Dupont et al., 2003) and are also likely also to be important for cAMP spikes. The versatility of both messengers is increased further by interactions between them (Bruce et al., 2003; Werry et al., 2003; Screaton et al., 2004; Willoughby and Cooper, 2007). Ca2+, for example, regulates cAMP formation and degradation, and by regulating protein kinases and calcineurin, it modulates many effects of protein kinase A (PKA). Conversely, cAMP regulates formation and phosphorylation of inositol 1,4,5-trisphosphate (IP3), the activities of Ca2+ channels and pumps, and formation of other Ca2+-mobilizing messengers. Such interactions endow cells with computational ability (Bray, 1995). Many proteins involved in cAMP and Ca2+ signaling exist in multiple isoforms, which may differ in behavior and expression. This diversity adds further to the complexity of the signaling pathways, but its physiological significance is incompletely understood.
###end p 7
###begin p 8
###xml 77 79 77 79 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 163 165 163 165 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 342 362 342 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib23">J&#252;ppner et al., 1991</xref>
###xml 364 382 364 382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib2">Behar et al., 1996</xref>
###xml 492 494 492 494 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 513 515 513 515 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 516 517 516 517 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i</sub>
###xml 559 561 559 561 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 696 697 693 694 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 699 719 696 716 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib23">J&#252;ppner et al., 1991</xref>
###xml 721 739 718 736 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib27">Mahon et al., 2006</xref>
###xml 806 813 800 801 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#949;</italic>
###xml 824 844 812 832 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib36">Schmidt et al., 2001</xref>
###xml 878 880 866 868 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 919 920 907 908 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 922 946 910 934 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib38">Seuwen and Boddeke, 1995</xref>
###xml 948 970 936 958 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib39">Short and Taylor, 2000</xref>
###xml 1028 1029 1016 1017 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1043 1044 1031 1032 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1047 1071 1035 1059 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib38">Seuwen and Boddeke, 1995</xref>
###xml 1078 1100 1066 1088 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib39">Short and Taylor, 2000</xref>
###xml 1102 1120 1090 1108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib45">Tovey et al., 2003</xref>
###xml 1134 1154 1122 1142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib9">Buckley et al., 2001</xref>
###xml 1194 1195 1182 1183 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1205 1207 1193 1195 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
Parathyroid hormone (PTH) plays a central role in the regulation of plasma Ca2+ concentration, although its receptors are also expressed in tissues unrelated to Ca2+ homeostasis. Each of the related PTH receptors (types 1 and 2) belongs to the family of G protein-coupled receptors that includes those for secretin, calcitonin, and glucagon (Juppner et al., 1991; Behar et al., 1996). PTH receptors share with these an ability to both stimulate adenylyl cyclase (AC) and increase cytosolic Ca2+ concentration ([Ca2+]i), but it is unclear how PTH stimulates Ca2+ release from intracellular stores. Some evidence suggests that PTH receptors stimulate PLC-beta via Gq or Gi, and thus formation of IP3 (Juppner et al., 1991; Mahon et al., 2006). PTH receptors might also, like beta-adrenoceptors, activate PLC-epsilon via cAMP (Schmidt et al., 2001). Other evidence suggests that Ca2+ release occurs without formation of IP3 (Seuwen and Boddeke, 1995; Short and Taylor, 2000), and perhaps even in the presence of an antagonist of IP3 receptors (IP3R; Seuwen and Boddeke, 1995). We (Short and Taylor, 2000; Tovey et al., 2003) and others (Buckley et al., 2001) have suggested that PTH potentiates IP3-evoked Ca2+ release, but the intracellular signals responsible have not been identified.
###end p 8
###begin p 9
###xml 94 95 94 95 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 225 226 225 226 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 231 232 231 232 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 254 255 254 255 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 287 288 287 288 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
Here, we find that PTH, and other receptors that stimulate cAMP formation, communicate with IP3R via intracellular "cAMP junctions," wherein cAMP passes directly from a specific isoform of AC (AC6) to a specific subtype of IP3R (IP3R2) to increase its IP3 sensitivity. This identifies IP3R as a new target for cAMP, an unexpected interaction between two ubiquitous signaling pathways, and a novel binary mode of cAMP signaling that allows robust digital recruitment of a response by graded concentrations of an extracellular stimulus.
###end p 9
###begin title 10
Results
###end title 10
###begin title 11
###xml 18 19 18 19 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 29 31 29 31 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
PTH potentiates IP3-evoked Ca2+ release entirely via cAMP
###end title 11
###begin p 12
###xml 83 84 83 84 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 101 103 101 103 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 181 189 181 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 A</xref>
###xml 226 228 226 228 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 382 384 382 384 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 385 386 385 386 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i</sub>
###xml 518 520 518 520 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 522 530 522 530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 A</xref>
###xml 551 553 551 553 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 594 595 594 595 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 602 603 602 603 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 638 660 638 660 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib39">Short and Taylor, 2000</xref>
###xml 662 680 662 680 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib45">Tovey et al., 2003</xref>
###xml 762 781 762 781 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib44">Takasu et al., 1999</xref>
###xml 839 841 839 841 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 851 866 851 866 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1, E and F</xref>
###xml 884 885 884 885 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 890 891 890 891 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 1011 1013 1011 1013 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 1080 1091 1080 1091 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1, B&#8211;D</xref>
###xml 1222 1239 1221 1238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib57">Zerr et al., 1996</xref>
###xml 1262 1264 1261 1263 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 1265 1266 1264 1265 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i</sub>
###xml 1361 1363 1360 1362 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 1364 1365 1363 1364 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i</sub>
###xml 1407 1430 1406 1429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib51">Willoughby et al., 2006</xref>
###xml 1526 1528 1523 1525 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 145 150 <span type="species:ncbi:9606">human</span>
###xml 273 278 <span type="species:ncbi:9606">human</span>
Carbachol (CCh), via endogenous muscarinic receptors, stimulates PLC and thereby IP3 formation and Ca2+ release from the intracellular stores of human embryonic kidney (HEK) cells (Fig. 1 A). In the absence of extracellular Ca2+, stimulation of HEK cells stably expressing human type 1 PTH receptors (HEK-PR1 cells) with a supramaximal concentration of CCh caused an increase in [Ca2+]i that returned to basal levels within 60-70 s. The addition of PTH, in the continued presence of CCh, evoked a further release of Ca2+ (Fig. 1 A). This additional Ca2+ release results from sensitization of IP3R to IP3 (Fig. S1, A and B, available at ; Short and Taylor, 2000; Tovey et al., 2003). Some analogues of PTH recruit other signaling pathways without stimulating AC (Takasu et al., 1999), but only the analogues that stimulate AC potentiated Ca2+ release (Fig. 1, E and F). Prostaglandin E1 (PGE1; unpublished data) and isoproterenol, which stimulate AC via their endogenous receptors, also potentiated CCh-evoked Ca2+ signals. So too did forskolin (FK), which directly stimulates AC (Fig. 1, B-D). However, 1,9-dideoxyforskolin (100 muM), an FK analogue that does not stimulate AC but mimics the AC-independent effects of FK (Zerr et al., 1996), had no effect on [Ca2+]i either alone or with CCh (unpublished data). None of these stimuli significantly increased [Ca2+]i in the absence of CCh (Fig. S1, C and D; Willoughby et al., 2006). Single cell analyses established that in most cells that responded to CCh (98 +/- 1%), the Ca2+ signal was potentiated by PTH (99 +/- 1%), isoproterenol (80 +/- 4%), and FK (95 +/- 3%).
###end p 12
###begin p 13
###xml 33 35 33 35 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 0 81 0 81 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Potentiation of CCh-stimulated Ca<sup>2+</sup> release by stimuli that evoke cAMP formation.</bold>
###xml 114 117 114 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bis</italic>
###xml 118 119 118 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink">o</italic>
###xml 140 141 140 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 142 143 142 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 144 145 144 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 147 148 147 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 202 204 202 204 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 249 251 249 251 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 357 359 357 359 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 432 434 432 434 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 435 436 435 436 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i</sub>
###xml 653 655 653 655 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 825 844 825 844 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib44">Takasu et al., 1999</xref>
Potentiation of CCh-stimulated Ca2+ release by stimuli that evoke cAMP formation. (A) After addition of 10 mM 1,2-bis(o-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid (BAPTA) to chelate extracellular Ca2+, 1 mM CCh stimulated transient release of Ca2+ from intracellular stores (black). 100 nM PTH in the continued presence of CCh then stimulated further Ca2+ release (red). (B) Effects of PTH, FK, and isoproterenol on the peak [Ca2+]i in the continued presence of 1 mM CCh. (C and D) Stimulation of cAMP production by PTH, FK, and isoproterenol (D is an enlargement of C). (E and F) Stimulation of cAMP production (E) and potentiation of CCh-evoked Ca2+ signals (F) in response to PTH(1-34), PTH(1-31), and PTH(3-34). Others have shown that PTH(1-31) stimulates AC but not PKC, whereas PTH(3-34) stimulates PKC but not AC (Takasu et al., 1999). Results are means +/- SEM from at least three experiments.
###end p 13
###begin p 14
###xml 126 128 126 128 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 138 149 138 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2, A&#8211;F</xref>
###xml 266 281 265 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib21">He et al., 2003</xref>
###xml 328 330 327 329 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 340 362 339 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib39">Short and Taylor, 2000</xref>
###xml 364 382 363 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib45">Tovey et al., 2003</xref>
###xml 459 461 458 460 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50</sub>
###xml 482 490 479 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 C</xref>
PTH and a high concentration of the membrane-permeant analogue of cAMP, 8-Br-cAMP (30 mM), similarly potentiated CCh-evoked Ca2+ signals (Fig. 2, A-F); 8-Br-cGMP (30 mM) was ineffective (not depicted). Much lower (<100 muM) concentrations of 8-Br-cAMP activate PKA (He et al., 2003), but they did not significantly potentiate Ca2+ signals (Short and Taylor, 2000; Tovey et al., 2003). The low sensitivity to 8-Br-cAMP (half-maximal effective concentration, EC50 = 0.87 +/- 0.37 mM; Fig. 2 C) is important and is discussed further in later sections.
###end p 14
###begin p 15
###xml 33 35 33 35 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 0 57 0 57 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Potentiation of CCh-stimulated Ca<sup>2+</sup> release by 8-Br-cAMP.</bold>
###xml 70 72 70 72 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 221 222 221 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 383 385 381 383 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 386 387 384 385 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i</sub>
###xml 495 497 493 495 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 513 515 511 513 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50</sub>
###xml 601 603 599 601 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 765 767 761 763 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
Potentiation of CCh-stimulated Ca2+ release by 8-Br-cAMP. (A and B) Ca2+ signals evoked by 1 mM CCh alone (black) or after prior treatment (red) with 8-Br-cAMP (A; 10 mM for 20 min) or PTH (B; 100 nM for 1 min). Results (n > 3 from one experiment; means +/- SEM) are typical of more than six experiments. (C and D) Effects of 8-Br-cAMP, 8-Br-2'-O-Me-cAMP (C), and PTH (D) on peak [Ca2+]i evoked by 1 mM CCh. (E) Effects of PTH (100 nM for 1 min) and 8-Br-cAMP (10 mM for 20 min) on CCh-evoked Ca2+ signals. (F) EC50 values and maximal responses (as a percentage of control) are shown for CCh-evoked Ca2+ signals after the indicated treatments. Results (C-F) are means +/- SEM from at least three experiments. (G) cAMP entirely mediates potentiation of CCh-evoked Ca2+ release.
###end p 15
###begin p 16
###xml 34 36 34 36 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 128 130 128 130 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 450 452 450 452 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 494 502 494 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 E</xref>
###xml 570 578 570 578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 F</xref>
###xml 635 637 635 637 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50</sub>
###xml 655 657 655 657 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 758 759 758 759 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 762 770 762 770 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 G</xref>
###xml 836 837 829 830 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 877 879 870 872 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 881 898 874 891 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib56">Zeng et al., 2003</xref>
###xml 969 971 962 964 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 1106 1122 1091 1107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib24">Law et al., 1993</xref>
###xml 1124 1147 1109 1132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib52">Willoughby et al., 2007</xref>
###xml 1211 1212 1196 1197 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1215 1223 1200 1208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 G</xref>
###xml 1299 1305 1284 1290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6</xref>
The extent to which the maximal Ca2+ release evoked by CCh can be enhanced is limited by the finite size of the intracellular Ca2+ stores, but there is no such limit on the extent to which the sensitivity to CCh can be increased. Two independently acting stimuli should cause an additive increase in CCh sensitivity. It is significant, therefore, that maximal concentrations of 8-Br-cAMP and PTH had the same effects on both the sensitivity of the Ca2+ signals to CCh and the maximal response (Fig. 2 E), and it is also significant that their effects were not additive (Fig. 2 F). The nonadditive effects of PTH and 8-Br-cAMP on the EC50 for CCh-evoked Ca2+ signals establish the fact that cAMP is the only signal linking PTH receptors to sensitization of IP3R (Fig. 2 G). G protein betagamma subunits have been reported to stimulate IP3R directly and so to cause release of Ca2+ (Zeng et al., 2003). PTH cannot work via this pathway because PTH does not alone cause Ca2+ release (Fig. S1), nor does somatostatin (1 muM), which activates Gi and thereby the release of betagamma subunits (unpublished data; Law et al., 1993; Willoughby et al., 2007). We conclude that cAMP alone mediates the effects of PTH on IP3R (Fig. 2 G). We provide additional evidence to support this key conclusion later (see Fig. 6).
###end p 16
###begin title 17
###xml 18 19 18 19 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
cAMP sensitizes IP3R independent of PKA and exchange proteins activated by cAMP (epacs)
###end title 17
###begin p 18
###xml 24 25 24 25 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 118 136 118 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib7">Bruce et al., 2003</xref>
###xml 138 168 138 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib41">Soulsby and Wojcikiewicz, 2007</xref>
###xml 173 174 173 174 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 198 199 198 199 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 223 230 223 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="tbl1">Table I</xref>
###xml 272 273 272 273 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 295 296 295 296 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 306 308 306 308 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 318 338 318 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib10">Burgess et al., 1991</xref>
###xml 340 358 340 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib7">Bruce et al., 2003</xref>
###xml 418 419 418 419 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 422 431 422 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Figs. 3 A</xref>
###xml 580 582 580 582 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 595 596 595 596 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 602 610 602 610 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 A</xref>
All three subtypes of IP3R can be phosphorylated by PKA, although at different sites and with different consequences (Bruce et al., 2003; Soulsby and Wojcikiewicz, 2007). IP3R2 is the major (46%) IP3R subtype in HEK cells (Table I), and in other cells expressing mainly IP3R2, PKA potentiates IP3-evoked Ca2+ release (Burgess et al., 1991; Bruce et al., 2003). In HEK-PR1 cells, PTH caused modest phosphorylation of IP3R (Figs. 3 A and S2 B, available at ), and PKA very slightly (though not to a statistically significant degree) increased the sensitivity of the intracellular Ca2+ stores to IP3 (see Fig. 4 A).
###end p 18
###begin title 19
###xml 35 36 35 36 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
Expression of subtypes of AC and IP3R in HEK-PR1 cells
###end title 19
###begin p 20
###xml 101 102 101 102 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 340 363 338 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib25">Ludwig and Seuwen, 2002</xref>
###xml 389 390 387 388 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 399 400 397 398 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 464 482 462 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib53">Wojcikiewicz, 1995</xref>
QPCR was used to measure relative levels (percentage of total) of mRNA encoding isoforms of AC and IP3R in HEK-PR1 cells. Results are means +/- SEM from three experiments, each performed in duplicate. The absence of AC2, AC4, and AC8 is consistent with a previous semiquantitative RT-PCR analysis, although a low level of AC5 was detected (Ludwig and Seuwen, 2002). The preponderance of IP3R2 and IP3R3 in HEK cells is consistent with results from immunoblotting (Wojcikiewicz, 1995).
###end p 20
###begin p 21
###xml 53 55 53 55 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 0 69 0 69 <bold xmlns:xlink="http://www.w3.org/1999/xlink">PKA is not required for potentiation of CCh-evoked Ca<sup>2+</sup> mobilization.</bold>
###xml 76 77 76 77 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 104 105 104 105 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 188 189 186 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 587 595 582 590 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 F</xref>
###xml 598 599 593 594 <sub xmlns:xlink="http://www.w3.org/1999/xlink">r</sub>
###xml 776 778 769 771 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 938 940 930 932 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 1060 1062 1051 1053 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 1228 1245 1216 1233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib33">Penn et al., 1999</xref>
###xml 1281 1282 1267 1268 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
PKA is not required for potentiation of CCh-evoked Ca2+ mobilization. (A) IP3R phosphorylation (AbP/AbIP3R3) is expressed relative to levels detected in unstimulated cells (means +/- SEM, n = 3-4). AbP is an anti-phospho Ser/Thr antibody (Table S1, available at ). (B) The effects of 8-Br-cAMP (10 mM for 20 min), FK (100 muM for 30 s), and PTH (100 nM for 30 s) on protein phosphorylation (assessed using AbP) alone or in the presence of H89 (89; 10 muM for 20 min) or st-ht31 (ht; 100 muM for 30 min). The arrow indicates the band used for quantification of protein phosphorylation in Fig. 5 F. Mr markers (kD) are indicated on the left. (C and D) The effect of H89 (C; 10 muM for 20 min) and st-ht31 (D; 100 muM for 30 min) on the ability of PTH to potentiate CCh-evoked Ca2+ mobilization. The targets of the inhibitors are shown in the insets. (E) The effect of H89 (10 muM for 20 min) on the ability of FK to potentiate CCh-evoked Ca2+ mobilization. (F) The effect of RpcAMPS (50 muM for 20 min) on the ability of isoproterenol to potentiate CCh-evoked Ca2+ signals. RpcAMPS was used to inhibit PKA because H89 decreased the sensitivity to isoproterenol by competing with it for occupancy of beta-adrenoceptors (Fig. S2 E; Penn et al., 1999). Results (C-F) are means +/- SEM, n >/= 3.
###end p 21
###begin p 22
###xml 131 139 131 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 B</xref>
###xml 149 157 149 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 F</xref>
###xml 177 192 177 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3, C and E</xref>
###xml 223 232 223 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Figs. 3 F</xref>
###xml 288 290 288 290 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 379 380 379 380 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 403 422 403 422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib42">Straub et al., 2002</xref>
###xml 463 483 463 483 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib54">Wong and Scott, 2004</xref>
###xml 570 593 570 593 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib51">Willoughby et al., 2006</xref>
###xml 730 738 730 738 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 B</xref>
###xml 803 805 803 805 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 843 851 843 851 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 D</xref>
###xml 892 893 892 893 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 938 939 938 939 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 988 989 988 989 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1056 1057 1056 1057 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1067 1069 1067 1069 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
PTH, FK, and 8-Br-cAMP stimulated phosphorylation of many proteins in HEK-PR1 cells, and H89, an inhibitor of PKA, prevented this (Fig. 3 B, and see Fig. 5 F). But neither H89 (Fig. 3, C and E) nor other inhibitors of PKA (Figs. 3 F and S2, C-F) affected potentiation of the CCh-evoked Ca2+ signals. A kinase-anchoring proteins (AKAPs) contribute to PKA-mediated inhibition of IP3R3 by cholecystokinin (Straub et al., 2002) and to many other PKA-mediated events (Wong and Scott, 2004). A membrane-permeant form of ht31 peptide (st-ht31), which uncouples AKAPs from PKA (Willoughby et al., 2006), blocked phosphorylation of many of the proteins phosphorylated in response to PTH and FK without affecting the response to 8-Br-cAMP (Fig. 3 B). But st-ht31 had no effect on the potentiation of CCh-evoked Ca2+ signals by FK (not depicted) or PTH (Fig. 3 D). We conclude that phosphorylation of IP3R by PKA slightly potentiates responses to IP3, and PTH stimulates modest phosphorylation of IP3R, but the phosphorylation is not required for PTH to potentiate IP3-evoked Ca2+ release.
###end p 22
###begin p 23
###xml 43 63 43 63 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib15">Dremier et al., 2003</xref>
###xml 121 138 121 138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib35">Rich et al., 2000</xref>
###xml 151 160 151 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib4">Bos, 2003</xref>
###xml 200 202 200 202 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 203 204 203 204 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i</sub>
###xml 273 280 273 274 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#949;</italic>
###xml 282 302 276 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib36">Schmidt et al., 2001</xref>
###xml 485 487 479 481 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 488 489 482 483 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i</sub>
###xml 500 523 494 517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib51">Willoughby et al., 2006</xref>
###xml 570 579 564 573 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Figs. 1 B</xref>
###xml 622 623 616 617 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 644 666 638 660 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib39">Short and Taylor, 2000</xref>
###xml 712 721 706 715 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib4">Bos, 2003</xref>
###xml 736 737 730 731 <italic xmlns:xlink="http://www.w3.org/1999/xlink">O</italic>
###xml 794 818 788 812 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib12">Christensen et al., 2003</xref>
###xml 955 957 949 951 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 1003 1011 997 1005 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 C</xref>
###xml 1061 1063 1055 1057 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 1111 1112 1105 1106 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1142 1143 1136 1137 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
Other proteins are also regulated by cAMP (Dremier et al., 2003), notably cyclic nucleotide-gated cation channels (CNGC; Rich et al., 2000) and epacs (Bos, 2003). Indeed, a cAMP-evoked increase in [Ca2+]i has been proposed to result from activation of epac, Rap 2, and PLC-epsilon (Schmidt et al., 2001). By Western blotting (WB), we detected expression of epac-1 (but not epac-2) in HEK-PR1 cells (unpublished data), but no significant effect of isoproterenol, PTH, or FK alone on [Ca2+]i (Fig. S1; Willoughby et al., 2006), although each potentiated responses to CCh (Figs. 1 B and S1). Nor did we detect formation of IP3 in response to PTH (Short and Taylor, 2000). Epacs are less sensitive than PKA to cAMP (Bos, 2003), but 8-Br-2'-O-methyladenosine-3',5'-cAMP selectively activates epacs (Christensen et al., 2003). Even very high concentrations (30 mM) of this analogue, which is more membrane-permeant than 8-Br-cAMP, had no effect on CCh-evoked Ca2+ signals, whereas 8-Br-cAMP potentiated them (Fig. 2 C). These results establish that potentiation of Ca2+ release by PTH results from sensitization of IP3R rather than production of IP3, and neither PKA nor epac is required.
###end p 23
###begin p 24
###xml 59 61 59 61 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50</sub>
###xml 80 95 78 93 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4, A and B</xref>
###xml 128 129 126 127 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 139 141 137 139 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 247 255 221 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 A</xref>
###xml 374 382 348 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 E</xref>
###xml 553 554 526 527 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 564 566 537 539 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 612 614 585 587 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50</sub>
###xml 633 648 603 618 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4, C and D</xref>
###xml 758 759 728 729 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 886 894 856 864 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 C</xref>
###xml 921 929 891 899 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 D</xref>
###xml 1026 1027 996 997 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1089 1090 1059 1060 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1141 1142 1111 1112 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1181 1182 1151 1152 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 1186 1187 1156 1157 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1201 1202 1171 1172 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1312 1321 1270 1279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib4">Bos, 2003</xref>
###xml 1385 1405 1331 1351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib54">Wong and Scott, 2004</xref>
###xml 1507 1508 1453 1454 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1511 1531 1457 1477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib15">Dremier et al., 2003</xref>
###xml 1594 1595 1540 1541 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
In permeabilized HEK cells, high concentrations of cAMP (EC50 = 2.7 +/- 1.0 mM; Fig. 4, A and B) increased the sensitivity of IP3-evoked Ca2+ release by approximately4.5-fold. This is much greater than the approximately30% increase evoked by PKA (Fig. 4 A) but similar to the three- to fourfold increase in the sensitivity to CCh evoked by PTH or 8-Br-cAMP in intact cells (Fig. 2 E). The responses of permeabilized cells to cAMP and of intact cells to 8-Br-cAMP were unaffected by inhibition of PKA (by 10 muM H89; unpublished data). Potentiation of IP3-evoked Ca2+ release by cAMP was mimicked by 8-Br-cAMP (EC50 = 324 +/- 45 muM; Fig. 4, C and D) but not by 5'-AMP, ATP, ADP, or GTP (10 mM; not depicted). This low-affinity interaction between cAMP and IP3R is consistent with only high concentrations of 8-Br-cAMP mimicking PTH in intact cells. Indeed, the sensitivities of intact (Fig. 2 C) and permeabilized cells (Fig. 4 D) to 8-Br-cAMP are similar. We conclude that cAMP binds directly to a low-affinity site on the IP3R (or an associated protein) to increase its sensitivity to IP3. The interaction is not mediated via changes in IP3 binding because cAMP has no effect on 3H-IP3 binding to IP3R2 (unpublished data). The affinity of this site for cAMP is approximately600-times lower than that of epacs (Bos, 2003) and approximately20,000-times lower than that of PKA or CNGC (Wong and Scott, 2004). It is unsurprising, therefore, that there is no known consensus sequence for cAMP binding within IP3R (Dremier et al., 2003). A novel low-affinity site mediates the effects of cAMP on IP3R.
###end p 24
###begin p 25
###xml 18 19 18 19 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 29 31 29 31 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 0 71 0 71 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Potentiation of IP<sub>3</sub>-evoked Ca<sup>2+</sup> release by cAMP in permeabilized cells.</bold>
###xml 78 80 78 80 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 134 135 134 135 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 310 312 310 312 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 372 374 372 374 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50</sub>
###xml 381 382 381 382 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 392 394 392 394 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 482 484 482 484 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 498 499 498 499 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 588 590 588 590 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50</sub>
###xml 597 598 597 598 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 608 610 608 610 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 705 713 705 713 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 C</xref>
###xml 881 883 881 883 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 1051 1052 1049 1050 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
Potentiation of IP3-evoked Ca2+ release by cAMP in permeabilized cells. (A) Ca2+ release from permeabilized HEK-PR1 cells evoked by IP3 alone, after treatment with the catalytic subunit of PKA (100 units per milliliter for 10 min) or 30 mM cAMP. Results are shown as a percentage of the ionomycin-releasable Ca2+ store. (B) Concentration-dependent effect of cAMP on the EC50 for IP3-evoked Ca2+ release from permeabilized HEK-PR1 cells. (C) Concentration-dependent stimulation of Ca2+ release by IP3 alone and with 3 mM 8-Br-cAMP. (D) Concentration-dependent effect of 8-Br-cAMP on the EC50 for IP3-evoked Ca2+ release. These results allow direct comparison with the effects of 8-Br-cAMP in intact cells (Fig. 2 C). The latter measurements were made after a 20-min preincubation with 8-Br-cAMP, and we have shown that although shorter preincubations cause lesser potentiation of Ca2+ signals, by 20 min, the response has reached its maximum. We conclude that 8-Br-cAMP equilibrates across the plasma membrane within 20 min. Results are means +/- SEM, n >/= 3.
###end p 25
###begin title 26
###xml 16 17 16 17 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
Regulation of IP3R by hyperactive cAMP junctions
###end title 26
###begin p 27
###xml 68 69 68 69 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 72 81 72 81 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Figs. 1&#8211;4</xref>
###xml 81 81 81 81 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig"/>
###xml 81 81 81 81 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig"/>
###xml 81 81 81 81 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig"/>
###xml 164 166 164 166 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 190 205 190 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5, A and B</xref>
###xml 306 308 306 308 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 309 310 309 310 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i</sub>
###xml 333 341 333 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 C</xref>
###xml 488 489 488 489 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 602 610 599 607 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7 E</xref>
###xml 682 697 679 694 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1, C and D</xref>
Despite the evidence that cAMP entirely mediates sensitization of IP3R (Figs. 1-4, S1, and S2), there is a massive disparity in the relationship between cAMP and Ca2+ for different stimuli (Fig. 5, A and B). This is most clear from the comparison of the amount of cAMP produced when each agonist causes [Ca2+]i to increase by 30 nM (Fig. 5 C). The disparity is inconsistent with global cAMP signals serving as a universal currency, which are used similarly by each stimulus to regulate IP3R. We note also that although HEK-PR1 cells express similar numbers of PTH receptors and beta-adrenoceptors (see Fig. 7 E), maximal activation with PTH causes a much greater stimulation of AC (Fig. 1, C and D), which suggests that an active PTH receptor stimulates AC more effectively than does an active beta-adrenoceptor.
###end p 27
###begin p 28
###xml 26 27 26 27 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 0 60 0 60 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Local cAMP signaling to IP<sub>3</sub>R via hyperactive cAMP junctions.</bold>
###xml 128 130 124 126 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 131 132 127 128 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i</sub>
###xml 271 273 267 269 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 274 275 270 271 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i</sub>
###xml 668 676 661 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 B</xref>
###xml 782 783 773 774 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 845 846 836 837 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1185 1186 1176 1177 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1267 1268 1258 1259 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1280 1281 1271 1272 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1349 1350 1340 1341 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
Local cAMP signaling to IP3R via hyperactive cAMP junctions. (A-C) The relationship between the increase (Delta) in cAMP and [Ca2+]i for each stimulus is shown (B is an enlargement of A to show FK and isoproterenol). The changes in cAMP associated with an increase in [Ca2+]i of 30 nM evoked by each stimulus are shown in C. (D and E) The effects of inhibitors of AC (SQ/DDA: 1 mM SQ 22536; 200 muM DDA for 20 min) and PDE (IBMX: 1 mM for 20 min) on responses to PTH. Results are means +/- SEM from four to five experiments. Similar results with FK and isoproterenol are shown in Fig. S3 (available at ). (F) Concentration-dependent phosphorylation of the 75-kD band (Fig. 3 B, arrow) after a 30-s treatment with PTH alone, and after pretreatment with SQ/DDA or H89 (means +/- SEM, n = 11). (G) Targets of the inhibitors. (H) Sensitization of IP3R in signaling complexes by receptors that generate supramaximal local concentrations of cAMP. The concentration-dependent effects of PTH (bottom) are proposed to arise from recruitment of these all-or-nothing junctions. (I) Steps preceding activation of AC might contribute to the surplus cAMP that allows communication between PTH and IP3R to survive massive inhibition of AC, but for FK, only cAMP separates it from IP3R. The AC-IP3R interaction thus defines the minimal signaling complex, the "AC-IP3R junction" (boxed).
###end p 28
###begin p 29
###xml 213 215 213 215 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 316 335 316 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib19">Fisher et al., 1998</xref>
###xml 358 360 358 360 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 410 418 410 418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 E</xref>
###xml 499 521 499 521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib39">Short and Taylor, 2000</xref>
###xml 583 585 583 585 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 618 619 618 619 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 662 663 662 663 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 700 722 700 722 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib39">Short and Taylor, 2000</xref>
###xml 947 953 947 953 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5</xref>
###xml 993 995 993 995 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 1081 1089 1081 1089 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 E</xref>
###xml 1181 1189 1181 1189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 F</xref>
###xml 1270 1277 1270 1271 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#949;</italic>
###xml 1279 1299 1273 1293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib36">Schmidt et al., 2001</xref>
Manipulation of cAMP levels by inhibiting either cAMP formation or its degradation by cyclic nucleotide phosphodiesterases (PDE) further highlights the inconsistent relationship between cAMP and potentiation of Ca2+ signals. 3-isobutyl-1-methylxanthine (IBMX), which inhibits most isoforms of PDE that degrade cAMP (Fisher et al., 1998), failed to enhance Ca2+ signals. Instead, it caused a slight inhibition (Fig. 5 E and S3 B, available at ) that became more pronounced with prolonged incubation (Short and Taylor, 2000). This probably results from activation of PKA and loss of Ca2+ from intracellular stores via IP3R made more sensitive to basal levels of IP3 after their phosphorylation by PKA (Short and Taylor, 2000). More strikingly, massive inhibition of cAMP formation with a combination of inhibitors of AC (9-(tetrahydro-29-furyl)adenine [SQ 22536] and 2',5'-dideoxyadenosine [DDA], referred to hereafter as SQ/DDA; see the legend for Fig. 5) failed to attenuate the potentiated Ca2+ signals evoked by any concentration of FK, isoproterenol (Fig. S3, B and D), or PTH (Fig. 5 E). The latter was the case even though SQ/DDA abolished PTH-evoked protein phosphorylation (Fig. 5 F), and much lower concentrations of DDA blocked epac-mediated stimulation of PLC-epsilon (Schmidt et al., 2001).
###end p 29
###begin p 30
###xml 54 55 54 55 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 88 97 88 97 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Figs. 1&#8211;4</xref>
###xml 97 97 97 97 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig"/>
###xml 97 97 97 97 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig"/>
###xml 97 97 97 97 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig"/>
###xml 176 178 176 178 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 180 191 180 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5, A&#8211;E</xref>
###xml 249 251 249 251 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 286 308 286 308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib39">Short and Taylor, 2000</xref>
###xml 524 526 524 526 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50</sub>
###xml 569 594 569 594 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib43">Strickland and Loeb, 1981</xref>
###xml 863 865 863 865 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50</sub>
###xml 914 916 914 916 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 994 1002 994 1002 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="tbl2">Table II</xref>
###xml 1262 1264 1262 1264 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 1379 1388 1379 1388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Figs. 5 E</xref>
###xml 1451 1452 1451 1452 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
Our results seem paradoxical. The effects of PTH on IP3R are mediated entirely by cAMP (Figs. 1-4), yet in intact cells, there is no consistent relationship between cAMP and Ca2+ (Fig. 5, A-E). This first led us to think that the effect of PTH on Ca2+ signals was not mediated by cAMP (Short and Taylor, 2000), but that conclusion is now untenable. Maximally activated receptors often generate more intracellular messenger than needed to evoke a maximal response. This allows downstream events to be more sensitive (lower EC50) than earlier ones to the initial signal (Strickland and Loeb, 1981). Such systems are said to have "spare receptors" because activation of only a fraction of the receptors can evoke a maximal response. Responses to maximal stimulation may then survive even substantial inhibition of downstream signaling. But in our experiments, the EC50 values for cAMP formation and potentiation of Ca2+ signals, measured under identical conditions, are similar for each stimulus (Table II). Furthermore, even when maximal stimulation generates surplus signal, a globally distributed messenger cannot have a safety margin when it evokes a submaximal response: reducing the amount of messenger must reduce the response. Yet in our experiments, the Ca2+ signals evoked by every concentration of each stimulus were entirely insensitive to substantial inhibition of AC (Figs. 5 E and S3, B and D). How can cAMP mediate graded regulation of IP3R and yet operate with a substantial safety margin at every level of stimulus intensity?
###end p 30
###begin title 31
###xml 79 81 79 81 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
Effects of PTH, FK, and isoproterenol on cAMP and potentiation of CCh-evoked Ca2+ signals
###end title 31
###begin p 32
###xml 24 25 22 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 94 96 92 94 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
Results (means +/- SEM, n = 3-10) show increases in cAMP and potentiation of the CCh-evoked Ca2+ signal evoked by each stimulus, with each response measured under identical conditions after a 30-s stimulation.
###end p 32
###begin p 33
###xml 34 35 34 35 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 66 73 66 73 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Figs. 3</xref>
###xml 245 246 245 246 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 249 257 249 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 H</xref>
###xml 411 412 411 412 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 586 594 586 594 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 H</xref>
###xml 838 839 838 839 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 842 850 842 850 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 I</xref>
###xml 901 902 901 902 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 919 921 919 921 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 1138 1139 1138 1139 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1213 1214 1213 1214 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1226 1234 1226 1234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 I</xref>
###xml 1432 1433 1432 1433 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1436 1444 1436 1444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 B</xref>
###xml 1599 1600 1599 1600 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1647 1664 1647 1664 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib35">Rich et al., 2000</xref>
###xml 1695 1696 1695 1696 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
We suggest that cAMP sensitizes IP3R independent of PKA and epac (Figs. 3 and S2). Signaling by cAMP must be local, and within a signaling complex, a receptor must generate substantially more cAMP than needed maximally to sensitize associated IP3R (Fig. 5 H). Each complex, or cAMP junction, operates with a large safety margin so that even substantial inhibition of AC fails to compromise communication with IP3R. The concentration-dependent effects of PTH (or FK) come from recruitment of increasing numbers of these hyperactive junctions and not from increased activity within each (Fig. 5 H). For receptors, the safety margin might arise at various steps of the signaling pathway: a single receptor might, for example, sustain the activity of more Gs than needed to stimulate sufficient AC to cause maximal activation of associated IP3R (Fig. 5 I). But for FK, only cAMP lies between it and the IP3R, and yet the Ca2+ signals evoked by any concentration of FK are also insensitive to substantial inhibition of AC (Fig. S3, A and B). Activation of a single AC can, therefore, deliver more cAMP than needed maximally to sensitize the IP3R associated with it. This defines the minimal signaling complex: an AC-IP3R junction (Fig. 5 I, box). The key point is that each active receptor (or AC) saturates the local signaling machinery and so functions as a local on-off switch. The very low affinity of the cAMP-binding site of the IP3R (Fig. 4 B) effectively insulates each signaling complex from its neighbors because diffusion will reduce the cAMP concentration to below that needed to sensitize IP3R within just a few nanometers of the complex (Rich et al., 2000). This digital signaling to IP3R imposes no requirement for individual PTH receptors (or AC) to differ in their sensitivities; PTH binding to a uniform population of PTH receptors, governed by the law of mass action, is sufficient to generate a graded increase in the number of active receptors as the PTH concentration increases.
###end p 33
###begin p 34
###xml 12 27 12 27 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5, H and I</xref>
###xml 52 53 52 53 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 187 189 187 189 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
Our scheme (Fig. 5, H and I) predicts that AC and IP3R are intimately associated, and that complete inhibition of cAMP formation within some junctions should more effectively attenuate Ca2+ signaling than partial inhibition of all junctions. Subsequent experiments confirm these predictions, but first we provide additional evidence that cAMP mediates the effects of PTH.
###end p 34
###begin p 35
###xml 111 119 107 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6 A</xref>
###xml 151 153 147 149 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 175 183 171 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6 B</xref>
###xml 266 274 262 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6 C</xref>
###xml 341 343 337 339 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 467 475 459 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6 D</xref>
###xml 567 568 559 560 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 713 714 701 702 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 717 725 705 713 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 G</xref>
We established stable HEK-PR1 cell lines in which expression of Galphas was reduced by >95% by means of siRNA (Fig. 6 A). In these cells, CCh-evoked Ca2+ signals were normal (Fig. 6 B), FK potentiated them, and the response to FK was unaffected by inhibitors of AC (Fig. 6 C). However, whereas inhibition of PKA again had no effect on the Ca2+ signals evoked by PTH, the sensitivity to PTH was reduced by inhibition of AC in cells with reduced expression of Galphas (Fig. 6 D). These results show that when the safety margin for signaling between PTH receptors and IP3R is eroded by removal of Galphas, the requirement for AC activity is unmasked. This further confirms that cAMP mediates the effects of PTH on IP3R (Fig. 2 G).
###end p 35
###begin p 36
###xml 85 87 81 83 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 0 96 0 92 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Inhibition of G&#945;s expression confirms that cAMP mediates the effects of PTH on Ca<sup>2+</sup> signals.</bold>
###xml 405 407 392 394 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 472 474 459 461 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 525 526 508 509 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 567 569 550 552 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 625 626 604 605 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 667 668 644 645 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
Inhibition of Galphas expression confirms that cAMP mediates the effects of PTH on Ca2+ signals. (A) WB showing expression of Galphas in HEK-PR1 cells before (black) and after (red) stable transfection with short hairpin RNA to Galphas (protein loadings are indicated in mug). Results are typical of at least three similar blots. Molecular weight markers are indicated in kD. (B) Effects of CCh on peak Ca2+ signals in the two cell lines. (C) Potentiation of CCh-evoked Ca2+ signals by FK alone or with SQ/DDA in HEK-PRalphas- cells. (D) Potentiation of CCh-evoked Ca2+ signals by PTH alone or with SQ/DDA or H89 HEK-PRalphas- cells. Results (B-D) are means +/- SEM, n = 3-6.
###end p 36
###begin title 37
###xml 10 11 10 11 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
AC6 and IP3R2 are specifically associated
###end title 37
###begin p 38
###xml 91 92 91 92 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 205 212 205 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="tbl1">Table I</xref>
###xml 279 280 279 280 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 307 308 307 308 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 317 318 317 318 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 322 337 322 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7, A and B</xref>
###xml 448 449 448 449 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 462 470 462 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7 B</xref>
###xml 540 541 540 541 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 545 553 545 553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7 C</xref>
###xml 608 615 608 615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="tbl1">Table I</xref>
###xml 680 681 680 681 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 723 738 723 738 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7, A and B</xref>
###xml 786 787 786 787 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 821 829 821 829 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7 B</xref>
###xml 923 925 923 925 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 957 958 957 958 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 985 1000 985 1000 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7, A and B</xref>
###xml 1053 1054 1053 1054 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1117 1118 1117 1118 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1130 1138 1130 1138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7 B</xref>
###xml 1273 1300 1273 1300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib50">Willoughby and Cooper, 2007</xref>
###xml 1302 1322 1302 1322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib1">Baragli et al., 2008</xref>
###xml 1399 1400 1399 1400 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1446 1447 1446 1447 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
We used immunoprecipitation (IP) to determine whether any of the many isoforms of AC and IP3R expressed in HEK cells are specifically associated. AC6 accounts for only 5% of the AC expressed in HEK cells (Table I), but an antibody to it (AbAC6) selectively precipitated 30% of IP3R2 and lesser amounts of IP3R3 and IP3R1 (Fig. 7, A and B). An antibody that recognizes all mammalian AC isoforms (AbACc) selectively precipitated the same amount of IP3R2 as AbAC6 (Fig. 7 B); and after IP with AbAC6, AbACc was unable to precipitate further IP3R2 (Fig. 7 C). AC3 comprises 56% of the AC expressed in HEK cells (Table I), and an antibody to it (AbAC3) selectively precipitated some IP3R2, but much less effectively than AbAC6 (Fig. 7, A and B). AC9 is also relatively abundant (10%), but IP3R were not precipitated by AbAC9 (Fig. 7 B and S4 D, available at ). None of the AbAC precipitated the sarcoplasmic reticulum (SR)/ER Ca2+-ATPase (SERCA), and nor were IP3R precipitated by AbSERCA (Fig. 7, A and B). These results establish that the association of IP3R with AC depends entirely on AC6. The lesser association of IP3R with AC3 (Fig. 7 B) may result from hetero-oligomerization of AC3 with AC6. Both isoforms appear to dimerize (Fig. S4 B), and AC does form heterodimers (Willoughby and Cooper, 2007; Baragli et al., 2008). We considered whether PTH might itself regulate association of AC6 with IP3R2, but the ability of AbAC6 to cause IP of IP3R2 was unaffected by PTH (unpublished data).
###end p 38
###begin p 39
###xml 10 11 10 11 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 0 42 0 42 <bold xmlns:xlink="http://www.w3.org/1999/xlink">AC6 and IP<sub>3</sub>R2 are specifically associated.</bold>
###xml 116 117 116 117 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 353 354 353 354 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 456 457 454 455 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 518 519 514 515 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 564 565 554 555 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 685 686 675 676 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 825 826 815 816 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 836 837 826 827 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1003 1004 993 994 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1152 1153 1142 1143 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1183 1184 1173 1174 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1264 1265 1254 1255 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1297 1298 1287 1288 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1345 1346 1335 1336 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1585 1587 1574 1576 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 1719 1720 1706 1707 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1914 1915 1899 1900 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 2204 2205 2189 2190 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
AC6 and IP3R2 are specifically associated. (A) Typical results showing WB (P, pellet; S, supernatant) after IP of IP3R or SERCA by the indicated antibodies. Here and in later panels, the calibrated molecular weights (kD) of the identified band are indicated. Black lines indicate that intervening lanes have been spliced out. (B) Percentages of total IP3R1-3 detected in the pellet after IP with the indicated antibodies from HEK-PR1 cells (means +/- SEM, n >/= 3). The efficiencies of the IP were similar for all AbIP3R (77 +/- 3%, 74 +/- 1%, and 78 +/- 9% for IP3R1-3, respectively). (C) After IP with AbAC6 (IP-1), a subsequent IP with AbAC6 or AbACc (IP-2) failed to precipitate IP3R. Results typical of two independent experiments are shown. (D) Results typical of three experiments show WB with AbGFP after IP with AbIP3R2 or AbIP3R3 from HEK-PR1 cells transiently transfected with AC6-GFP or AC3-GFP (Fig. S4, available at ). The results show that only AC6 is immunoprecipitated, and only by AbIP3R2. The results were not further quantified because overexpression of AC probably prevents more than a small fraction of it from associating with IP3R. (E) We suggest that only IP3R2 and AC6 interact directly (top), but hetero-oligomeric assemblies of AC or IP3R may allow lesser amounts of IP3R3 subunits or AC3 to associate with the AC6-IP3R2 junction. (F) HEK-PR1 cells were stimulated with 100 nM PTH for either 30 s (as before; not depicted, but responses were indistinguishable from those after 5 min) or 5 min before addition of 30 muM CCh. Potentiation of the CCh-evoked Ca2+ signals by the indicated concentrations of PTH (5 min) alone or with SQ/DDA or H89 (20 min) are shown. The results (means +/- SEM, n >/= 3) demonstrate that after prolonged treatment with PTH (to allow PKA-mediated recruitment of PDE), responses remain insensitive to inhibition of AC or PKA. (G) The association of AC6 and IP3R2 is intimate enough to deny cAMP access to PDE as it passes between them, whereas local signaling between AC and the higher-affinity cAMP sensors (PKA, epac, or CNGC) occurs over longer distances and remains accessible to PDE. Diffusion of cAMP is sufficient to terminate signaling to IP3R, whereas PDE assembled into signaling complexes regulates local events mediated by the other cAMP sensors.
###end p 39
###begin p 40
###xml 42 43 42 43 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 136 163 136 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib50">Willoughby and Cooper, 2007</xref>
###xml 376 377 376 377 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 392 393 392 393 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 439 447 439 447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7 D</xref>
###xml 477 478 477 478 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 549 550 549 550 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 614 615 614 615 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 685 686 685 686 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 707 715 707 715 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7 E</xref>
###xml 208 213 <span type="species:ncbi:9606">human</span>
Reciprocal IP from native cells using AbIP3R was impossible because available AC antibodies do not reliably detect endogenous AC in WB (Willoughby and Cooper, 2007). We therefore transiently expressed tagged human AC3 and AC6 in HEK cells, and confirmed that each AbAC selectively precipitated only the appropriate AC (Fig. S4, A-C). In the transiently transfected cells, AbIP3R2 but not AbIP3R3 selectively precipitated AC6, but not AC3 (Fig. 7 D). We conclude that AC6 and IP3R2 are specifically associated. The lesser associations with AC3 and IP3R3 probably result from interactions between heterotetrameric IP3R (Fig. S2 A) and dimeric AC (Fig. S4 B) that include the essential IP3R2 and AC6 subunits (Fig. 7 E).
###end p 40
###begin p 41
###xml 25 26 25 26 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 40 47 40 47 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="tbl1">Table I</xref>
###xml 52 58 52 58 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig8" ref-type="fig">Fig. 8</xref>
###xml 143 144 119 120 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 193 194 157 158 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 221 222 185 186 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 247 248 199 200 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 276 284 228 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7 B</xref>
###xml 353 354 305 306 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 447 448 399 400 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 452 460 404 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7 E</xref>
Our analysis of AC and IP3R expression (Table I and Fig. 8) suggest that a HEK cell expresses approximately1,500 AC6 and approximately13,300 IP3R2 subunits (approximately3,300 homotetrameric IP3R2), and at least 30% of IP3R2 (approximately1,000 IP3R) are associated with AC6 (Fig. 7 B). These estimates cannot reliably define the stoichiometry of the IP3R2-AC6 complex, but they are consistent with each AC6 associating with a single tetrameric IP3R2 (Fig. 7 E).
###end p 41
###begin p 42
###xml 0 37 0 37 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Quantification of signaling proteins.</bold>
###xml 213 214 210 211 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 428 429 421 422 <sub xmlns:xlink="http://www.w3.org/1999/xlink">d</sub>
###xml 565 568 558 561 <sub xmlns:xlink="http://www.w3.org/1999/xlink">max</sub>
###xml 580 581 573 574 <sub xmlns:xlink="http://www.w3.org/1999/xlink">d</sub>
###xml 599 600 590 591 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
Quantification of signaling proteins. (A-D) Equilibrium competition binding curves for each of the ligands are shown. Results show the expression levels of PTH receptors (A), beta-adrenoceptors (B), AC (C), and IP3R (D) in HEK-PR1 cells. (E) Summary of the numbers of the signaling proteins expressed in each HEK-PR1 cell. For Galphas, this was calculated from calibrated WB, and for receptors and FK, it was computed from the Kd and the specific binding (S) determined for a defined concentration ([L]) of radioligand of known specific activity with the formula: Bmax = S(1+[L]/Kd). Means +/- SEM, n >/= 3.
###end p 42
###begin title 43
###xml 5 6 5 6 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
AC-IP3R junctions are inaccessible to PDE
###end title 43
###begin p 44
###xml 90 113 90 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib51">Willoughby et al., 2006</xref>
###xml 141 164 141 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib52">Willoughby et al., 2007</xref>
###xml 313 314 313 314 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 316 339 316 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib51">Willoughby et al., 2006</xref>
###xml 359 382 359 382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib52">Willoughby et al., 2007</xref>
###xml 510 511 498 499 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 560 561 533 534 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 577 600 550 573 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib51">Willoughby et al., 2006</xref>
###xml 754 756 727 729 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 844 852 817 825 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7 F</xref>
###xml 996 997 969 970 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1028 1029 1001 1002 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1085 1094 1058 1067 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Figs. 5 E</xref>
###xml 1204 1219 1177 1192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3, A and B</xref>
###xml 1225 1234 1198 1207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Figs. 7 F</xref>
###xml 1295 1296 1268 1269 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1361 1384 1334 1357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib51">Willoughby et al., 2006</xref>
###xml 1479 1480 1452 1453 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1543 1551 1516 1524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7 G</xref>
###xml 1581 1582 1554 1555 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1806 1807 1779 1780 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 2063 2087 2036 2060 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib14">Dodge-Kafka et al., 2005</xref>
###xml 2089 2112 2062 2085 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib51">Willoughby et al., 2006</xref>
###xml 2114 2118 2087 2091 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib52">2007</xref>
###xml 2136 2137 2109 2110 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 2541 2549 2514 2522 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7 G</xref>
In HEK cells, phosphorylation by PKA of PDE4D anchored to the plasma membrane by an AKAP (Willoughby et al., 2006) or recruited by arrestin (Willoughby et al., 2007) massively accelerates cAMP degradation. This rapidly attenuates the increase in cAMP immediately beneath the plasma membrane, whether evoked by PGE1 (Willoughby et al., 2006) or isoproterenol (Willoughby et al., 2007). Our measurements (at 30 s) precede maximal activation of this PDE, which occurs approximately1 min after stimulation with PGE1 and approximately3 min after stimulation of beta2-adrenoceptors (Willoughby et al., 2006). However, when the interval between PTH and CCh additions was extended to 5 min to allow maximal activation of anchored PDE4D by PKA, the potentiated Ca2+ signals remained insensitive to inhibition of AC or PKA at every concentration of PTH (Fig. 7 F). These results demonstrate that even when PDE is massively stimulated, inhibition of AC fails to attenuate cAMP-mediated communication with IP3R. Nor is communication with IP3R improved by inhibiting PDE either directly with IBMX (Figs. 5 E and S3, B and D) or indirectly by preventing its recruitment and activation by PKA-mediated phosphorylation (Fig. 3, A and B; and Figs. 7 F and S2). We conclude that the interaction between AC6 and IP3R2 is more intimate than that between AC and PKA, epac, or CNGC (Willoughby et al., 2006), even though the latter detect only cAMP immediately beneath the plasma membrane. Only the IP3R allows cAMP to evade PDE as it passes from AC to its target (Fig. 7 G). We conclude that AC6 and IP3R2 are specifically associated, and their intimacy is sufficient to allow cAMP to pass between them without encountering PDE. This reveals an important distinction between two different modes of cAMP signaling: binary (to IP3R) and analogue (to PKA and epac). Because epac and PKA bind cAMP with high affinity, they can respond in a graded fashion to cAMP diffusing to them from a distant AC, but they then assemble with PDE to ensure effective local degradation of the messenger (Dodge-Kafka et al., 2005; Willoughby et al., 2006, 2007). In contrast, IP3R, with their low affinity for cAMP, must be very close to AC, but diffusion alone is enough to terminate the signaling. Both modes of cAMP signaling generate spatially organized responses: the analogue mode used by high-affinity cAMP sensors relies on local degradation of cAMP, whereas the binary mode requires local synthesis of cAMP to deliver it at high concentration to a low-affinity cAMP sensor (Fig. 7 G).
###end p 44
###begin title 45
###xml 18 19 18 19 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 29 31 29 31 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 79 80 79 80 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
Potentiation of IP3-evoked Ca2+ signals by PTH specifically requires AC6 and IP3R2
###end title 45
###begin p 46
###xml 57 58 57 58 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 64 65 64 65 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 83 91 83 91 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig9" ref-type="fig">Fig. 9 A</xref>
###xml 96 105 96 105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="tbl3">Table III</xref>
###xml 138 139 138 139 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 208 210 208 210 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 267 268 267 268 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 287 289 287 289 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 380 381 380 381 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 407 409 407 409 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 480 495 480 495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig9" ref-type="fig">Fig. 9, B and C</xref>
###xml 569 571 569 571 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 632 634 632 634 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 659 660 659 660 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 678 680 678 680 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 720 721 720 721 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 764 772 764 772 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig9" ref-type="fig">Fig. 9 D</xref>
###xml 916 918 916 918 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 1034 1036 1034 1036 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 1046 1061 1046 1061 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig9" ref-type="fig">Fig. 9, E and F</xref>
###xml 1070 1072 1070 1072 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 1220 1221 1220 1221 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1248 1254 1248 1254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7</xref>
###xml 1312 1314 1312 1314 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
We used siRNA to inhibit selectively the expression of IP3R2, IP3R1, AC3, and AC6 (Fig. 9 A and Table III). Although siRNA also reduced IP3R3 expression, these cells failed to attach to the plates used for Ca2+ and cAMP assays, preventing further analysis. Loss of IP3R1 decreased the Ca2+ signals evoked by CCh without affecting their potentiation by PTH. In contrast, loss of IP3R2 had no affect on the Ca2+ signals evoked by CCh alone but attenuated their potentiation by PTH (Fig. 9, B and C). These results suggest that the muscarinic receptors that alone evoke Ca2+ release are distributed differently to those that release Ca2+ in synergy with cAMP. IP3R1 mediates the Ca2+ release evoked by CCh alone, whereas IP3R2 mediates the response to CCh with cAMP (Fig. 9 D). Loss of AC3, the major AC isoform, reduced PTH-evoked cAMP formation, though without affecting the ability of PTH to potentiate CCh-evoked Ca2+ signals. Conversely, loss of AC6 had no detectable effect on PTH-evoked cAMP formation but attenuated PTH-evoked Ca2+ signals (Fig. 9, E and F). The Ca2+ release evoked by CCh alone was unaffected by loss of AC3 or AC6 (Fig. S4, E and F). These results confirm that the specific association between IP3R2 and AC6 revealed by IP (Fig. 7) underlies the ability of PTH to potentiate CCh-evoked Ca2+ signals.
###end p 46
###begin p 47
###xml 2 3 2 3 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 64 65 64 65 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 75 77 75 77 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 0 86 0 86 <bold xmlns:xlink="http://www.w3.org/1999/xlink">IP<sub>3</sub>R2 and AC6 are specifically required for PTH to potentiate IP<sub>3</sub>-evoked Ca<sup>2+</sup> release.</bold>
###xml 196 197 196 197 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 212 213 212 213 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 355 356 351 352 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 420 421 413 414 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 429 430 422 423 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 460 462 453 455 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 519 521 512 514 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 573 581 566 574 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 A</xref>
###xml 772 774 761 763 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 814 815 803 804 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 833 835 822 824 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 910 911 899 900 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1040 1042 1029 1031 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 1506 1508 1467 1469 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 1552 1553 1511 1512 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
IP3R2 and AC6 are specifically required for PTH to potentiate IP3-evoked Ca2+ release. (A) WB (representative of five experiments) shows the effects of siRNA (boxed in red) on the expression of IP3R1 (260 kD), IP3R2 (260 kD), and beta-adaptin (100 kD; protein loadings are given in mug; molecular weight standards are indicated in kD). Each block shows IP3R above and beta-adaptin below. (B and C) Effects of reducing IP3R1 or IP3R2 expression on CCh-evoked Ca2+ signals (B) and the potentiation of CCh (1 mM)-evoked Ca2+ signals by PTH (C). The latter were measured as in Fig. 1 A. Results are means +/- SEM of triplicate determinations from a single experiment. Insets show the maximal responses (means +/- SEM) from four to five independent siRNA treatments. (D) The Ca2+ release evoked by CCh alone requires IP3R1, whereas the Ca2+ release evoked by CCh acting in concert with cAMP specifically requires IP3R2. (E and F) Effects of reducing AC3 or AC6 expression on PTH-evoked cAMP formation (E) and on the potentiation of CCh-evoked Ca2+ signals by PTH (F). Results are means +/- SEM from at least five independent siRNA treatments; the main panel in F shows means +/- SEM of triplicate determinations from a single experiment. (G) Summary showing that uniform inhibition (by approximately60-70%) of AC by SQ/DDA massively inhibits PTH-evoked cAMP formation, whereas a comparable (approximately60-70%) loss of AC6 (using siRNA) has no detectable effect on cAMP formation but attenuates PTH-mediated Ca2+ signaling. Results indicate means +/- SEM, n >/= 3.
###end p 47
###begin title 48
###xml 47 48 47 48 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
Selective inhibition of expression of AC and IP3R isoforms
###end title 48
###begin p 49
###xml 151 152 149 150 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 284 286 282 284 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 287 288 285 286 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i</sub>
###xml 299 305 297 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig9" ref-type="fig">Fig. 9</xref>
###xml 334 335 332 333 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
Quantification of levels of expression (percentage of control, means +/- SEM from three to five independent transfections) of the isoforms of AC and IP3R from HEK-PR1 cells treated with the indicated siRNA. Samples were taken from the same cells that were used for measurements of [Ca2+]i and cAMP (Fig. 9). WB was used to quantify IP3R expression and QPCR for AC (available antibodies are incapable of detecting endogenous levels of AC). ND, not determined.
###end p 49
###begin p 50
Indicates the extent to which expression of the target protein was reduced.
###end p 50
###begin title 51
###xml 51 53 51 53 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
Focal inhibition of AC more effectively inhibits Ca2+ signaling than global inhibition
###end title 51
###begin p 52
###xml 80 88 80 88 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 H</xref>
###xml 190 191 190 191 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 301 318 301 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib34">Reid et al., 1990</xref>
###xml 466 468 454 456 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 480 495 468 483 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5, D and E</xref>
###xml 707 708 695 696 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 711 726 699 714 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5, H and I</xref>
###xml 860 862 836 838 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 924 926 900 902 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50</sub>
###xml 1002 1010 974 982 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig9" ref-type="fig">Fig. 9 F</xref>
###xml 1137 1139 1109 1111 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 1344 1346 1316 1318 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 1421 1429 1393 1401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig9" ref-type="fig">Fig. 9 G</xref>
Because we propose that each cAMP junction operates with a large safety margin (Fig. 5 H), complete inhibition of AC within some junctions should more effectively inhibit sensitization of IP3R than partial inhibition of AC within all junctions. SQ 22536 and DDA are low-affinity inhibitors of all AC (Reid et al., 1990) that should rapidly and uniformly distribute their inhibition across all AC. Such uniform inhibition of AC by approximately70% does not inhibit Ca2+ signaling (Fig. 5, D and E; and Fig. S3). In contrast, inhibition of AC6 expression by siRNA is expected to cause random loss of AC from individual signaling complexes, each perhaps comprising only a dimeric AC associated with a single IP3R (Fig. 5, H and I). A 62% loss of AC6 (approximately3% of total AC) had no detectable effect on PTH-evoked cAMP formation but inhibited PTH-mediated Ca2+ signaling by 30% without affecting the sensitivity to PTH (EC50 = 63 +/- 3 nM and 54 +/- 5 nM, before and after loss of AC6, respectively; Fig. 9 F). These results confirm our second prediction. When all AC (and thus all AC6) is uniformly inhibited by 60-70% (by SQ/DDA), Ca2+ signaling is unaffected. In contrast, the same overall loss of AC6 activity, though distributed in an all-or-nothing fashion between junctions (by reducing AC6 expression), reduces the magnitude of the Ca2+ signals without affecting the PTH sensitivity of the remaining junctions (Fig. 9 G).
###end p 52
###begin title 53
###xml 48 49 48 49 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
Direct cAMP-mediated signaling between AC and IP3R
###end title 53
###begin p 54
###xml 67 69 67 69 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 216 225 216 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Figs. 1&#8211;4</xref>
###xml 225 225 225 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig"/>
###xml 225 225 225 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig"/>
###xml 225 225 225 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig"/>
###xml 300 309 300 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Figs. 2 C</xref>
###xml 314 317 314 317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">4 D</xref>
###xml 449 450 449 450 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 642 657 642 657 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1, C and D</xref>
###xml 745 746 733 734 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 813 814 801 802 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 894 896 882 884 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 1000 1009 976 985 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig10" ref-type="fig">Fig. 10 A</xref>
###xml 1129 1137 1105 1113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 B</xref>
We can compare quantitatively the relationships between cAMP and Ca2+ because each was measured at the same time under identical conditions, all cells responded similarly, and cAMP alone mediates the effects of PTH (Figs. 1-4). The similar sensitivity of intact and permeabilized cells to 8-Br-cAMP (Figs. 2 C and 4 D) confirms the fact that permeabilized cells retain their sensitivity to cAMP. This allows comparisons of the cAMP sensitivity of IP3R in permeabilized cells with the calculated concentrations of cAMP evoked by PTH if cAMP were uniformly distributed through the cytosol. For PTH, which produces more cAMP than other stimuli (Fig. 1, C and D), the calculated cAMP concentrations are approximately1,000-fold too low to modulate IP3R. The disparity is even greater when AC is inhibited and the AC-IP3R junctions operate with a reduced safety margin. Therefore, the half-maximal Ca2+ signal evoked by PTH is associated with an estimated global cAMP concentration of approximately500 nM (Fig. 10 A), whereas the half-maximal response in permeabilized cells requires a 5,400-fold higher concentration of cAMP (2.7 mM; Fig. 4 B).
###end p 54
###begin p 55
###xml 0 38 0 38 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Binary and analogue signaling by cAMP.</bold>
###xml 82 83 82 83 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 93 95 93 95 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 228 230 228 230 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 347 364 334 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib35">Rich et al., 2000</xref>
###xml 426 427 413 414 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
###xml 824 825 770 771 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 847 848 793 794 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 916 917 862 863 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 947 949 893 895 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 968 969 914 915 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1063 1065 1009 1011 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 1091 1092 1037 1038 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1236 1255 1182 1201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib47">Treves et al., 2004</xref>
###xml 1257 1274 1203 1220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib26">Luik et al., 2006</xref>
###xml 1287 1288 1233 1234 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1339 1340 1285 1286 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1941 1943 1887 1889 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 2006 2043 1952 1989 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib13">Di Biase and Franzini-Armstrong, 2005</xref>
Binary and analogue signaling by cAMP. (A) Comparison of the effects of cAMP on IP3-evoked Ca2+ release from permeabilized cells with estimates of the global cAMP concentration associated with agonist-mediated potentiation of Ca2+ signals in intact cells. A typical HEK cell has a radius of 8.4 mum and thus a total volume of approximately2.5 pl (Rich et al., 2000). Each well used for cAMP assays contained a mean of 4.8 x 105 cells, and our results show cAMP levels determined in 20% of the sample taken from each well, equivalent therefore to 96,000 cells and a total cytosolic volume of 0.24 mul. Maximal stimulation with each agonist would generate a uniformly distributed cytosolic cAMP concentration of up to approximately28 muM (PTH), approximately1 muM (FK), and approximately380 nM (isoproterenol). Means +/- SEM, n = 3-6. (B) AC6 and IP3R2 form an intimate junction that allows cAMP to pass directly to IP3R2, enhancing its activity. Ca2+ released by the IP3R may then locally inhibit AC6. The interplay may allow local oscillations in both cAMP and Ca2+ concentration. (C) AC, IP3R, Gs, and a G-protein-coupled receptor (GPCR) are each drawn to approximate scale, with the ER and plasma membrane (PM) separated by 10-15 nm (Treves et al., 2004; Luik et al., 2006). (D) The IP3R-AC junction allows a low-affinity cAMP-sensor (IP3R2) to respond robustly to saturating concentrations of cAMP delivered directly to it by AC. Higher affinity cAMP sensors (e.g., PKA) can be more remote from AC and respond to local gradients of cAMP. Although the binary coding requires local delivery of cAMP, the analogue coding requires its local degradation. The two modes of cAMP signaling invite comparison with the evolution of excitation-contraction coupling in striated muscle, where coupling between the PM voltage-sensor (DHPR) and ryanodine receptor (RyR) in the SR of striated muscle probably evolved from chemical coupling mediated by Ca2+ (cardiac muscle) to conformational coupling (skeletal muscle; Di Biase and Franzini-Armstrong, 2005).
###end p 55
###begin p 56
###xml 82 99 82 99 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib35">Rich et al., 2000</xref>
###xml 101 124 101 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib51">Willoughby et al., 2006</xref>
###xml 126 130 126 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib52">2007</xref>
###xml 267 284 267 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib35">Rich et al., 2000</xref>
###xml 477 478 477 478 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 562 579 562 579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib35">Rich et al., 2000</xref>
###xml 672 698 672 698 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib32">Olveczky and Verkman, 1998</xref>
###xml 727 728 727 728 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 809 810 809 810 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 871 872 871 872 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 884 890 884 890 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7</xref>
###xml 934 935 934 935 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1004 1013 1004 1013 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig10" ref-type="fig">Fig. 10 B</xref>
###xml 1015 1033 1015 1033 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib22">Huang et al., 2001</xref>
Subplasma membrane microdomains of cAMP occur in many cells, including HEK cells (Rich et al., 2000; Willoughby et al., 2006, 2007). But the highest local concentrations of free cAMP achieved, whether measured or estimated from the activity of AC and cAMP diffusion (Rich et al., 2000), exceed the global cytosolic cAMP concentration by no more than 10-fold, even within a few nanometers of AC. Cytosolic cAMP concentrations, even very close to AC, are far too low to affect IP3R directly, and restricting the escape of cAMP with internal membranes like the ER (Rich et al., 2000) might further increase the local cAMP concentration by no more than approximately twofold (Olveczky and Verkman, 1998). Cyclic AMP cannot reach IP3R via the cytosol at concentrations sufficient to cause their sensitization to IP3. We instead suggest that the intimate association between IP3R2 and AC6 (Fig. 7) allows cAMP to pass directly from AC to IP3R in a manner analogous to substrate channeling in enzyme complexes (Fig. 10 B; Huang et al., 2001).
###end p 56
###begin title 57
Discussion
###end title 57
###begin title 58
###xml 10 11 10 11 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
AC6 and IP3R2: the most intimate mode of cAMP signaling
###end title 58
###begin p 59
###xml 71 72 71 72 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 79 80 79 80 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 219 220 219 220 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 278 279 278 279 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 327 328 327 328 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 338 340 338 340 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 367 368 367 368 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 427 428 427 428 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 637 638 637 638 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 788 790 788 790 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 792 819 792 819 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib50">Willoughby and Cooper, 2007</xref>
###xml 867 868 867 868 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 936 937 936 937 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 964 965 964 965 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 999 1000 999 1000 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1023 1025 1023 1025 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 1027 1036 1027 1036 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig10" ref-type="fig">Fig. 10 B</xref>
###xml 1120 1122 1120 1122 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 1174 1201 1174 1201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib20">Gorbunova and Spitzer, 2002</xref>
###xml 1203 1223 1203 1223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib17">Dyachok et al., 2006</xref>
We have shown that receptors that stimulate cAMP formation sensitize IP3R to IP3 via a pathway that requires neither PKA nor epac, but which is instead mediated by a novel low-affinity cAMP-binding site on either the IP3R itself or an associated protein. A complex of AC6 and IP3R2 is uniquely required for PTH to potentiate IP3-evoked Ca2+ release. Within each AC-IP3R junction, cAMP is delivered directly to the associated IP3R at a supersaturating concentration, allowing the junction to work as a robust on-off switch. Graded responses to changes in the intensity of the extracellular stimulus arise from digital recruitment of AC-IP3R junctions and not from graded activity of individual junctions. The presence of AC6 in these junctions is significant because AC6 is inhibited by Ca2+ (Willoughby and Cooper, 2007). It is therefore likely that within the AC6-IP3R2 junction, there will be a reciprocal interplay between AC6 and IP3R, with AC6 potentiating IP3R activity via cAMP, and active IP3R inhibiting AC6 via Ca2+ (Fig. 10 B). These feedback interactions may generate highly localized oscillations in both Ca2+ and cAMP similar to those observed in whole cells (Gorbunova and Spitzer, 2002; Dyachok et al., 2006).
###end p 59
###begin p 60
###xml 9 10 9 10 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 283 292 271 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig10" ref-type="fig">Fig. 10 D</xref>
###xml 371 373 359 361 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 501 538 489 526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib13">Di Biase and Franzini-Armstrong, 2005</xref>
###xml 657 659 645 647 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 671 690 659 678 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib47">Treves et al., 2004</xref>
###xml 692 711 680 699 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib48">Varnai et al., 2007</xref>
###xml 755 756 743 744 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 774 783 762 771 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig10" ref-type="fig">Fig. 10 C</xref>
###xml 814 815 802 803 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1040 1042 1028 1030 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 1080 1117 1068 1105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib13">Di Biase and Franzini-Armstrong, 2005</xref>
###xml 1149 1150 1137 1138 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1265 1274 1253 1262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig10" ref-type="fig">Fig. 10 B</xref>
The AC-IP3R junction suggests an analogy with excitation-contraction coupling in striated muscle, where voltage-sensing dihydropyridine receptors (DHPR) in the plasma membrane regulate opening of ryanodine receptors in the SR across a narrow (approximately10 nm) junctional complex (Fig. 10 D). Coupling of these proteins has evolved from chemical coupling mediated by Ca2+ (cardiac excitation-contraction coupling) to a physical coupling between the two apposed proteins (vertebrate skeletal muscle; Di Biase and Franzini-Armstrong, 2005). Junctional complexes similar to those in striated muscle occur also in nonexcitable cells; they are implicated in Ca2+ signaling (Treves et al., 2004; Varnai et al., 2007), and their width (10-15 nm) would allow IP3R and AC to abut (Fig. 10 C). We speculate that the AC6-IP3R2 complex may occur within such junctions, and that its evolution from the looser relationship between AC and PKA mediated by soluble cAMP may be similar to the evolution of conformational coupling in skeletal muscle from Ca2+-mediated coupling in cardiac muscle (Di Biase and Franzini-Armstrong, 2005). The difference is that AC6-IP3R2 communication requires not only direct contact but also passage of a constrained messenger, cAMP, between them (Fig. 10 B).
###end p 60
###begin p 61
###xml 6 7 6 7 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 58 59 58 59 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 104 105 104 105 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 141 142 141 142 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 166 175 166 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig10" ref-type="fig">Fig. 10 B</xref>
###xml 205 206 205 206 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 254 262 254 262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 H</xref>
###xml 415 416 415 416 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 471 472 471 472 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 750 759 750 759 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Figs. 7 G</xref>
###xml 764 768 764 768 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig10" ref-type="fig">10 D</xref>
The IP3R is a new and important target of cAMP. The AC6-IP3R2 complex allows cAMP to pass directly to IP3R and increase its sensitivity to IP3. These cAMP junctions (Fig. 10 B) allow robust signaling to IP3R because they are hyperactive on-off switches (Fig. 5 H). Increasing stimulus intensities recruit additional junctions, rather than increasing the activity within individual junctions. Signaling by cAMP to IP3R is binary, requires direct contact between AC6 and IP3R2, and relies on diffusion of cAMP to terminate the response of each junction. Other sensors with greater affinity for cAMP, like PKA and epac, respond to graded changes in local cAMP concentration (analogue signaling) and rely on PDE activity to shape local signaling events (Figs. 7 G and 10 D). These different modes of signaling considerably increase the versatility of cAMP as an intracellular messenger.
###end p 61
###begin title 62
Materials and methods
###end title 62
###begin title 63
Materials
###end title 63
###begin p 64
###xml 145 148 145 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bis</italic>
###xml 149 150 149 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink">o</italic>
###xml 171 172 171 172 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 173 174 173 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 175 176 175 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 178 179 178 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 238 239 238 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink">O</italic>
###xml 295 296 295 296 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 659 660 659 660 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 401 406 <span type="species:ncbi:9606">Human</span>
###xml 490 495 <span type="species:ncbi:9606">human</span>
DDA, cAMP, 8-Br-cAMP, 8-Br-cGMP, H89 dihydrochloride, ionomycin, KT5720, adenosine 3',5'-cyclic phosphorothioate-Rp (RpcAMPS), SQ 22536, and 1,2-bis(o-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid (BAPTA) were obtained from EMD. 8-Br-2'-O-methyladenosine-3',5'-cAMP was obtained from Biolog. IP3 was obtained from American Radiolabeled Chemicals. Thapsigargin was obtained from Alomone Laboratories. Human PTH fragments were obtained from Bachem; unless specifically stated, "PTH" denotes human PTH(1-34). Cell culture media, G-418, Fluo-4AM, Fura-2AM, Mag-fluo-4AM, and Pluronic F-127 were obtained from Invitrogen. Acetic anyhydride, CCh, carbonyl cyanide-p-trifluoromethoxyphenylhydrazone, FK, 1,9-dideoxyforskolin, IBMX, (+/-)-isoproterenol hydrochloride, the porcine catalytic subunit of PKA, and triethylamine were obtained from Sigma-Aldrich. St-ht31 was obtained from Promega.
###end p 64
###begin title 65
Cells, vectors, and siRNA
###end title 65
###begin p 66
###xml 53 75 53 75 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib39">Short and Taylor, 2000</xref>
###xml 119 120 119 120 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 188 189 188 189 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
###xml 429 430 429 430 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 464 465 464 465 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 655 656 655 656 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
###xml 820 844 820 844 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib8">Brummelkamp et al., 2002</xref>
###xml 1118 1120 1112 1114 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
HEK-PR1 cells were cultured as described previously (Short and Taylor, 2000). For siRNA-mediated inhibition of AC or IP3R expression, HEK-PR1 cells were seeded into 6-well plates (2.5 x 105 cells per well). After 24 h, the medium was replaced (2.5 ml) and Stealth siRNA duplex (30 pmol; Invitrogen) was added in Opti-MEM 1 + Glutamax (0.5 ml) containing 1% lipofectamine RNAimax (Invitrogen). The siRNA sequences (5'-3') were: IP3R1 (GGCCUGAGAGUUACGUGGCAGAAAU), IP3R2 (GAGAAGGCUCGAUGCUGAGACUUGA), AC3 (CCUCUGAAGAUGAGCACGAGCUCAA), and AC6 (CCAGCAUCUUCCUGCUGCUGCUAAU). After 24 h, cells were reseeded into 96-well (2,500 cells per well) or 6-well plates (105 cells per well), and after a further 48 h, the transfection with siRNA was repeated. Cells were incubated for a further 72 h before use. A modified pSUPER vector (Brummelkamp et al., 2002) was used to generate short hairpin RNA-mediated knockdown of Galphas in HEK-PR1 cells. Transfected cells were selected using 10 mug/ml blasticidin and 800 mug/ml G418, and clonally isolated cells were used to establish the seven cell lines used for analyses of cAMP and Ca2+ signaling.
###end p 66
###begin title 67
Transient expression of tagged AC3 and AC6
###end title 67
###begin p 68
###xml 28 33 <span type="species:ncbi:9606">human</span>
###xml 259 262 <span type="species:ncbi:34205">AC3</span>
The open reading frames for human AC3 (AK122926) in pME18SFL3 (National Institute of Technology and Evaluation Biological Resource Center) and AC6 (BC064923) in pCMV-Sport 6 (GeneService) were cloned as EcoRI-XhoI fragments into pENTR1a (Invitrogen). A Flag (AC3) or Myc (AC6) tag was introduced at the N terminal by PCR. Tagged and untagged AC constructs were subcloned into the pEGFP-C2 vector (Clontech Laboratories, Inc.) to generate AC constructs N-terminally tagged with EGFP (Fig. S4 A). HEK-PR1 cells were transfected using lipofectamine and used after 2 d.
###end p 68
###begin title 69
###xml 19 21 19 21 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 22 23 22 23 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i</sub>
Measurements of [Ca2+]i
###end title 69
###begin p 70
###xml 121 123 121 123 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 124 125 124 125 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i</sub>
###xml 230 248 230 248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib46">Tovey et al., 2006</xref>
###xml 356 358 356 358 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 420 422 420 422 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 423 424 423 424 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i</sub>
###xml 464 482 464 482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib45">Tovey et al., 2003</xref>
###xml 570 572 570 572 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 582 584 582 584 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 650 652 650 652 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 740 742 740 742 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 775 776 775 776 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 786 788 786 788 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 823 841 823 841 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib46">Tovey et al., 2006</xref>
Near confluent cultures of HEK-PR1 cells grown in 96-well plates and loaded with Fluo-4 were used for measurements of [Ca2+]i in cell populations using a FlexStation 96-well fluorescence spectrometer (MDS Analytical Technologies; Tovey et al., 2006). The results reported herein span >4 yr, but all direct comparisons between stimuli or between cAMP and Ca2+ were made in parallel experiments. Single cell imaging of [Ca2+]i was performed as described previously (Tovey et al., 2003), and after correction for autofluorescence, fluorescence ratios were calibrated to [Ca2+] using Ca2+ standard solutions (Invitrogen). CCh stimulation was always in Ca2+-free Hepes-buffered saline (HBS; except in Fig. S1, C and D). A low-affinity luminal Ca2+ indicator was used to measure IP3-evoked Ca2+ release from permeabilized cells (Tovey et al., 2006).
###end p 70
###begin title 71
Measurements of cAMP
###end title 71
###begin p 72
###xml 162 163 162 163 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 176 177 176 177 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 334 336 334 336 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 337 338 337 338 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i</sub>
###xml 916 923 913 914 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#949;</italic>
###xml 923 926 914 917 <sub xmlns:xlink="http://www.w3.org/1999/xlink">258</sub>
###xml 947 967 938 958 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib6">Brooker et al., 1979</xref>
###xml 1067 1086 1058 1077 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib28">Marley et al., 1991</xref>
###xml 1194 1195 1185 1186 <italic xmlns:xlink="http://www.w3.org/1999/xlink">O</italic>
###xml 1205 1208 1196 1199 <sup xmlns:xlink="http://www.w3.org/1999/xlink">125</sup>
###xml 1511 1512 1494 1495 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g</italic>
###xml 970 976 <span type="species:ncbi:9986">rabbit</span>
HEK-PR1 cells in 24-well plates were cultured for 2-3 d (as described in a preceding section). They were washed twice in HBS (135 mM NaCl, 5.9 mM KCl, 1.2 mM MgCl2, 1.5 mM CaCl2, 11.6 mM Hepes, and 11.5 mM glucose, pH 7.3) and then incubated under identical conditions (including addition of CCh) to those used for measurements of [Ca2+]i; the only difference was the omission of Fluo-4-AM and Pluronic F-127 from the 1-h incubation. After stimulation, the medium was aspirated, and the cells were lysed by the addition of acidified ice-cold ethanol (10 mM HCl in absolute ethanol). Dried extracts in 500 mul of medium (50 mM sodium acetate, 1 mM theophylline, and 1 mg/ml BSA, pH 5.0) were acetylated by rapid sequential addition of 10 mul triethylamine and 5 mul acetic anhydride. Acetylated cAMP content was determined by RIA using acetylated standards prepared from a cAMP stock calibrated by its UV absorption (epsilon258 = 14,100). For RIA (Brooker et al., 1979), rabbit antiserum to acetylated cAMP (P.D. Marley, University of Melbourne, Melbourne, Australia; Marley et al., 1991) was used at a final concentration of 1:9,000, and 8.4 TBq/mmol adenosine 3',5'-cyclic phosphoric acid, 2'-O-succinyl[125]iodotyrosine methyl ester (PerkinElmer) was used as tracer. Assays (300 mul) included 100 mul of sample. After incubation for 48 h at 4degreesC, 2 mg/ml BSA and 2 mg/ml Norit A charcoal were added in 50 mM sodium phosphate buffer at pH 7.4, and the free and antibody-bound tracer were separated (1,000 g for 10 min).
###end p 72
###begin title 73
IP and Western blotting
###end title 73
###begin p 74
###xml 62 63 56 57 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 430 431 424 425 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 432 433 426 427 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 434 435 428 429 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 446 447 440 441 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 449 450 443 444 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 594 595 588 589 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g</italic>
###xml 846 847 838 839 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g</italic>
###xml 1085 1086 1075 1076 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g</italic>
###xml 684 690 <span type="species:ncbi:9986">rabbit</span>
All procedures were performed at 4degreesC. A confluent 175-cm2 flask of HEK-PR1 cells was washed in 50 ml PBS supplemented with protease inhibitors (one tablet of Roche complete protease inhibitor per 50 ml). Cells were scraped into 1.5 ml solubilization medium, sonicated (three times for 10 s), and incubated with rotation for 1 h. Solubilization medium had the following composition: 140 mM NaCl, 5 mM NaF, 10 mM Tris, 1 mM Na4P2O7, 0.4 mM Na3VO4, 1% Triton X-100, pH 7.4, and one mini-tablet of Roche protease cocktail inhibitor per 10 ml. Cell debris was removed by centrifugation (5,000 g for 10 min) and the supernatant was cleared by incubation (1 h) with 5 mul of preimmune rabbit serum. Protein agarose Ig A/G beads (10 mul; Autogen Bioclear) were added, and after 2 h, immunoprecipitated material was removed by centrifugation (1,000 g for 1 min). An aliquot (300 mul) of the cleared lysate was incubated with the primary antiserum (Table S1, available at ) for 1 h before addition of protein A/G-agarose beads (50 mul) and incubation for 12 h. After centrifugation (1,000 g for 1 min), the supernatant and pellet (washed three times) were used for WB. WB used 3-8% Tris acetate NuPAGE gels (Invitrogen), and blots were quantified using a GeneGnome (SynGene) with gel loadings adjusted to ensure that intensities scaled linearly with protein loading. Antibodies are listed in Table S1.
###end p 74
###begin title 75
Quantitative PCR (QPCR)
###end title 75
###begin p 76
###xml 217 240 216 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib25">Ludwig and Seuwen, 2002</xref>
###xml 247 248 246 247 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 356 377 355 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib31">Ogunwobi et al., 2006</xref>
###xml 489 490 485 486 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 861 880 833 852 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib29">Moneer et al., 2005</xref>
cDNA was synthesized in a final volume of 20 mul directly from cell lysate using Fastlane cell cDNA kit (QIAGEN) according to the manufacturer's instructions. For QPCR, each reaction included primers specific for AC (Ludwig and Seuwen, 2002) or IP3R subtypes (Quantitect Primer Assay; QIAGEN), and for calibration, primers for a house-keeping gene (GAPDH; Ogunwobi et al., 2006). Each reaction (25 mul) contained 1 mul of the HEK-PR1 reverse-transcription product, 0.5 muM of the AC- or IP3R-specific primers, and Quantace Sensimix according to the manufacturer's instructions (Bioline). For PCR (Rotor-Gene 6000; Corbett Life Sciences), an initial denaturation at 93degreesC for 10 min was followed by 40 cycles of amplification (93degreesC for 10 s, 50-65degreesC for 15 s, and 72degreesC for 20 s). Expression levels were calculated as described previously (Moneer et al., 2005).
###end p 76
###begin title 77
Quantification of signaling proteins
###end title 77
###begin p 78
###xml 134 135 122 123 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 203 204 191 192 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 208 209 196 197 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 261 262 249 250 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 290 291 278 279 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 362 363 350 351 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 377 378 365 366 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 549 550 536 537 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 554 555 541 542 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 591 592 578 579 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 640 641 627 628 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 749 767 733 751 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib18">Emala et al., 2000</xref>
###xml 892 893 876 877 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 897 898 881 882 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 938 939 916 917 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 975 976 947 948 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 1037 1038 1009 1010 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g</italic>
###xml 1184 1187 1149 1152 <sup xmlns:xlink="http://www.w3.org/1999/xlink">125</sup>
###xml 1235 1236 1200 1201 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
###xml 1345 1348 1310 1313 <sup xmlns:xlink="http://www.w3.org/1999/xlink">125</sup>
###xml 1406 1426 1365 1385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib11">Chauvin et al., 2002</xref>
###xml 1676 1678 1635 1637 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50</sub>
###xml 1692 1693 1651 1652 <sub xmlns:xlink="http://www.w3.org/1999/xlink">D</sub>
###xml 1700 1703 1659 1662 <sub xmlns:xlink="http://www.w3.org/1999/xlink">max</sub>
HEK-PR1 cells were washed in HBS supplemented with a complete protease inhibitor cocktail (Roche) and resuspended (approximately4 x 106 cells per milliliter) in TM (50 mM Tris and 1 mM EDTA, pH 8.3) for 3H-IP3 binding, in DM (75 mM Tris, 1 mM EDTA, 12.5 mM MgCl2, and 0.2% BSA, pH 7.4) for 3H-dihydroalprenolol (DHA) binding, and in FM (50 mM Tris and 10 mM MgCl2, pH 7.4) for 3H-FK binding. Cells were lysed (Polytron, Inc.), and the lysates were used for equilibrium competition binding assays. Incubations, in a final volume of 500 mul, included 3H-IP3 (1.5 nM, 21 Ci/mmol; PerkinElmer), 3H-DHA (0.165 nM, 97 Ci/mmol; GE Healthcare), or 3H-FK (10 nM, 27 Ci/mmol; PerkinElmer; with 100 muM p[NH]ppG, 10 muM isoproterenol, and 40 muM cytochalasin; Emala et al., 2000); each with appropriate concentrations of unlabeled competing ligand. After equilibrium had been attained (5 min on ice for 3H-IP3, 90 min at 25degreesC with shaking for 3H-DHA, and 10 min at 25degreesC for 3H-FK), incubations were terminated by centrifugation (20,000 g for 5 min at 4degreesC) and the pellet was washed with cold buffer, then resuspended in 200 mul of buffer for liquid scintillation counting. For 125I-PTH binding, cells in 24-well plates (2-5 x 105 cells per well) were incubated in PM (Dulbecco's modified Eagles medium with 20 mM Hepes and 0.1% BSA) with 125I-PTH (44 pM, 1559 Ci/mmol; Bachem) for 5 h at 4degreesC (Chauvin et al., 2002). Cells were washed twice with ice-cold PBS and lysed with 0.8 M NaOH, then their radioactivity was determined. Equilibrium competition binding curves were fitted to four parameter logistic equations (GraphPad Prism; GraphPad Software) from which IC50 (and thence KD) and Bmax values were calculated. Expression of Galphas was quantified by WB, calibrated using recombinant Galphas (EMD).
###end p 78
###begin title 79
Analysis
###end title 79
###begin p 80
###xml 194 196 194 196 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50</sub>
###xml 215 216 215 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink">h</italic>
###xml 284 286 284 286 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50</sub>
###xml 337 339 335 337 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50</sub>
###xml 393 394 391 392 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
Concentration-effect relationships were individually fitted to four-parameter logistic equations by nonlinear curve-fitting (Prism 4; GraphPad Software), and the results from each experiment (EC50, Hill coefficient h, and maximal response) were pooled for analyses. For simplicity, EC50 values are given as means +/- SEM, although log EC50 values were used for statistical analysis. Student's t test, or a one-way analysis of variance test followed by a post hoc Bonferroni's test were used as was appropriate.
###end p 80
###begin title 81
Online supplemental material
###end title 81
###begin p 82
###xml 37 39 37 39 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 65 66 65 66 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 106 108 106 108 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 271 273 271 273 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 418 420 418 420 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 385 388 <span type="species:ncbi:34205">AC3</span>
Fig. S1 shows that PTH potentiates Ca2+ signals by sensitizing IP3R. Fig. S2 shows that potentiation of Ca2+ responses by isoproterenol and FK does not require PKA. Fig. S3 shows that inhibition of cAMP formation or degradation does not directly effect potentiation of Ca2+ responses by isoproterenol or FK. Fig. S4 shows the selectivity of the AC antibodies and the lack of effect of AC3 or AC6 siRNA on CCh-evoked Ca2+ release. Table S1 lists the antibodies used. Online supplemental material is available at .
###end p 82
###begin title 83
Supplementary Material
###end title 83
###begin title 84
[Supplemental Material Index]
###end title 84
###begin p 85
We thank P. Marley, S. Yarwood, and G. Milligan for antisera to acetylated-cAMP, epac-1, and Galphas, respectively; and M. Falcke (Berlin) for advice on diffusion.
###end p 85
###begin p 86
This work was supported by the Wellcome Trust (072084).
###end p 86

